Pharmaceutical firms witness sales edge up, but falling profits in Q3
Published: 2012-11-19 07:00:00
Updated: 2012-11-19 07:00:00
After comprehensive price cuts of drugs by the government in April. local drug companies witnessed a sales stagnation during the third quarter of this year, but fell short of reaping more profits than the previous quarter, data showed Thursday.
Combined sales by 52 listed firms rose 1.1 percen...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
